Jasper Therapeutics Stock Options

JSPR Stock  USD 2.34  0.01  0.43%   
Jasper Therapeutics' latest option contracts expiring on January 16th 2026 are carrying combined implied volatility of 2.87 with a put-to-call open interest ratio of 0.03 over 10 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on January 16th 2026.

Open Interest Against January 16th 2026 Option Contracts

The chart above shows Jasper Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Jasper Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Jasper Therapeutics' option, there is no secondary market available for investors to trade.

In The Money vs. Out of Money Option Contracts on Jasper Therapeutics

Analyzing Jasper Therapeutics' in-the-money options over time can help investors to take a profitable long position in Jasper Therapeutics regardless of its overall volatility. This is especially true when Jasper Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Jasper Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Jasper Therapeutics' stock while costing only a fraction of its price.

Jasper Current Options Market Mood

Jasper Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Jasper Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Jasper Therapeutics' options investors are not very successful. Jasper Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Jasper contract

Base on the Rule 16, the options market is currently suggesting that Jasper Therapeutics will have an average daily up or down price movement of about 0.18% per day over the life of the 2026-01-16 option contract. With Jasper Therapeutics trading at USD 2.34, that is roughly USD 0.004197. If you think that the market is fully incorporating Jasper Therapeutics' daily price movement you should consider buying Jasper Therapeutics options at the current volatility level of 2.87%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Jasper Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Jasper calls. Remember, the seller must deliver Jasper Therapeutics stock to the call owner when a call is exercised.

Jasper Therapeutics Option Chain

When Jasper Therapeutics' strike price is surpassing the current stock price, the option contract against Jasper Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Jasper Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Jasper. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Jasper. It also shows strike prices and maturity days for a Jasper Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
JSPR260116C000125001412.50.0 - 4.90.38Out
Call
JSPR260116C000100005010.00.0 - 0.70.15Out
Call
JSPR260116C000075002227.50.0 - 0.60.15Out
Call
JSPR260116C0000500015695.00.0 - 0.650.4Out
Call
JSPR260116C000025004632.50.7 - 1.20.95Out
 Put
JSPR260116P00012500012.57.6 - 12.57.6In
 Put
JSPR260116P00010000010.05.5 - 10.25.5In
 Put
JSPR260116P0000750027.53.0 - 7.82.8In
 Put
JSPR260116P00005000425.00.55 - 5.42.7In
 Put
JSPR260116P00002500232.50.1 - 4.81.0In

Jasper Total Stockholder Equity

Total Stockholder Equity

50.5 Million

At this time, Jasper Therapeutics' Total Stockholder Equity is relatively stable compared to the past year.

Jasper Therapeutics Corporate Management

Kimberly BaxterVP QualityProfile
Daniel MDMember OfficerProfile
Luca NotoSenior OperationsProfile
Carol ZoltowskiVP QualityProfile

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.